|
Morphometric analysis |
||||
| Control |
Probucol |
LXS |
HXS |
|
|
|
||||
| MIT (mm) |
0.89 ± 0.40 |
0.54 ± 0.15 |
0.48 ± 0.08 |
0.34 ± 0.05* |
| LA (mm2) |
0.90 ± 1.18 |
1.35 ± 0.83 |
1.88 ± 0.91 |
2.01 ± 0.88 ▲ |
| IELa (mm2) |
2.20 ± 0.65 |
2.16 ± 0.64 |
2.62 ± 1.03 |
2.52 ± 0.76 |
| EELa (mm2) |
3.22 ± 0.63 |
3.34 ± 0.62 |
3.68 ± 1.18 |
3.40 ± 0.64 |
| MA (mm2) |
1.02 ± 0.11 |
1.18 ± 0.43 |
1.06 ± 0.47 |
0.88 ± 0.30 |
| IA (mm2) |
1.30 ± 0.68 |
0.81 ± 0.68 |
0.74 ± 0.14 |
0.51 ± 0.27 |
| RL (%) |
34.00 ± 37.00 |
62.00 ± 24.00 ▲ |
70.00 ± 7.00 ▲▲ |
77.00 ± 14.00 |
| PI |
0.43 ± 0.23 |
0.24 ± 0.18 ▲ |
0.21 ± 0.04 ▲▲ |
0.16 ± 0.09 ▲▲ |
|
Values are mean ± SD. *P < 0.05, significance vs. control: comparison of group means after ANOVA; ▲ P < 0.05, ▲▲ P < 0.01, significance vs. control: comparison of group means after ANOVA taking injury score as covariance. | ||||
Xu et al. Chinese Medicine 2006 1:2 doi:10.1186/1749-8546-1-2 |
||||